Therapeutic Botulinum Toxin – Market Insights – Global

The COVID-19 pandemic will have a negative short-term effect on the global therapeutic BTX market. The deferral of nonurgent procedures, compounded with economic uncertainty across the globe will hinder procedure volumes and therefore impede market growth. Beyond the COVID-19 pandemic, the global therapeutic BTX market will grow strongly through 2029, with newly approved indications, the need for repeat BTX treatments, and a largely favorable reimbursement environment driving significant procedure volume and unit sales expansion.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, France, Germany, Italy, Spain, the UK, Japan and Australia across a 10-year period.

The COVID-19 pandemic will hinder growth of the global therapeutic BTX market in the near-term.

To what extent will COVID-19 impact the therapeutic BTX market globally?

Which geographies have experienced the largest impact, and how quickly are procedure volumes expected to recover?

How are manufacturers preparing for the postpandemic environment?

New indication approvals and existing indication expansions will be significant drivers in the therapeutic BTX market.

Which indications contribute the most to growth?

What regional differences exist regarding indication approvals?

What new indications have the largest market potential?

The global therapeutic markets are becoming more and more consolidated.

What are some key competitive strategies being employed to succeed in the market?

How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?

Markets vary greatly by region in terms of size and growth, with the US market experiencing the fastest growth globally.

What key drivers contribute to a market's relative size and growth?

What factors most significantly affect pricing within markets?

 

Ongoing clinical trials and emerging products could have a significant impact on the BTX market in the future.

 Which clinical trials have been successful and will have significant impact on the market?

Will emerging products expand on or compete against the existing BTX market?

What are some potential competitive advantages emerging products might have?

How will alternative treatments impact the BTX market?

Table of contents

  • Therapeutic Botulinum Toxin - Market Insights - Global
    • Abstract
    • Global
    • Executive Summary
      • COVID-19 Updates
        • Market Highlights
          • Factors Impacting the Therapeutic BTX Market, Global
          • Therapeutic BTX Market, by Region, Global (USD), 2019u20132030
          • Therapeutic BTX Market Landscape, Global (USD), 2020 and 2030
        • Competitive Highlights
          • Competitive Factors and Strategies, by Region
          • Therapeutic BTX Revenue Market Share Rankings, by Region, Global, 2020
          • Companies Mentioned
        • Market Developments
          • Recent Events in the Therapeutic BTX Market, Global
          • Key Clinical Trials in the Therapeutic BTX Market, Global
          • Emerging Products for the Therapeutic BTX Market, Global
        • Geographies Covered
          • Geographies Covered, Global
          • Average Currency Exchange Rates
        • Procedures Covered
          • Therapeutic BTX Procedures Covered, US
          • Approved Indications, by Brand, US, 2020/2021
          • Therapeutic BTX Procedures Covered, Europe
          • Approved Indications, by Brand, Europe, 2020/2021
          • Therapeutic BTX Procedures Covered, Asia Pacific
          • Approved Indications, by Brand, Asia Pacific, 2020/2021
        • Products Covered
          • Therapeutic BTX Product Overview, Global, 2020/2021
      • Key Report Updates
        • COVID-19 Analysis
          • Market Impact
            • COVID-19 Impact Assessment Summary, Therapeutic BTX Market, Global
          • Major Market Forecast Changes and Assumptions
            • Therapeutic BTX Market, by Region, Global (USD), 2019u20132030 (Excluding COVID-19 Impact)
            • Therapeutic BTX Market, by Region, Global (USD), 2019u20132030 (Including COVID-19 Impact)
          • Competitive Impact
            • COVID-19 Competitive Factors and Strategies, Therapeutic BTX Market, Global
            • COVID-19 Financial Impact and Competitor Insights
        • Global Therapeutic Botulinum Toxin Market
          • Market Highlights
            • Factors Impacting the Therapeutic BTX Market, Global
            • Therapeutic BTX Market, by Region, Global (USD), 2019u20132030
          • Market Definitions
            • Therapeutic BTX Product Overview, Global, 2020/2021
            • Mean Dosages, by Indication and Brand, Global
            • BTX Units Used per Procedure, by Indication, Global
            • BTX Product Equivalencies, by Brand
            • Approved Indications, by Brand, US, 2020/2021
            • Approved Indications, by Brand, Europe, 2020/2021
            • Approved Indications, by Brand, Asia Pacific, 2020/2021
          • Market Forecast Data
            • Therapeutic BTX Procedures, by Indication, Global, 2019u20132030
            • Therapeutic BTX Procedures, by Region, Global, 2019u20132030
            • Therapeutic BTX Market, by Indication, Global (USD), 2019u20132030
            • Therapeutic BTX Market, by Region, Global (USD), 2019u20132030
            • Therapeutic BTX Market Growth, by Region, Global, 2020u20132030
          • Competitive Highlights
            • Market Shares
              • Therapeutic BTX Revenue Market Shares, Global, 2020
              • Therapeutic BTX Revenue Market Shares, by Region, Global, 2020
            • Competitive Factors and Strategies
              • Competitive Factors and Strategies, by Region
            • Market Developments
              • Recent Events in the Therapeutic BTX Market, Global
              • Key Clinical Trials in the Therapeutic BTX Market, Global
              • Emerging Products for the Therapeutic BTX Market, Global
          • US Therapeutic Botulinum Toxin Market
            • Market Highlights
              • Therapeutic BTX Market, US (USD), 2019u20132030
            • Market Definitions
              • Market Forecast Data
                • Therapeutic BTX Procedures, by Indication, US, 2019u20132030
                • Spasticity Therapeutic BTX Procedures, by Anatomy, US, 2019u20132030
                • Spasticity Therapeutic BTX Procedures, by Age Group, US, 2019u20132030
                • Overactive Bladder Therapeutic BTX Procedures, by Cause, US, 2019u20132030
                • Therapeutic BTX Market, by Indication, US (USD), 2019u20132030
                • Therapeutic BTX Market, US (USD), 2019u20132030
              • Competitive Highlights
                • Market Shares
                  • Therapeutic BTX Revenue Market Shares, US 2020
                  • Therapeutic BTX Revenue Market Shares, US, 2020
                • Competitive Factors and Strategies
                  • Competitive Factors and Strategies, US
              • European Therapeutic Botulinum Toxin Market
                • Market Highlights
                  • Therapeutic BTX Market, by Country, Europe (USD), 2019u20132030
                • Market Definitions
                  • Market Forecast Data
                    • Therapeutic BTX Procedures, by Indication, Europe, 2019u20132030
                    • Therapeutic BTX Procedures, by Country, Europe, 2019u20132030
                    • Therapeutic BTX Procedures, by Indication, France, 2019u20132030
                    • Therapeutic BTX Procedures, by Indication, Germany, 2019u20132030
                    • Therapeutic BTX Procedures, by Indication, Italy, 2019u20132030
                    • Therapeutic BTX Procedures, by Indication, Spain, 2019u20132030
                    • Therapeutic BTX Procedures, by Indication, UK, 2019u20132030
                    • Therapeutic BTX Market, by Indication, Europe (USD and EUR), 2019u20132030
                    • Therapeutic BTX Market, by Country, Europe (USD), 2019u20132030
                    • Therapeutic BTX Market, by Country, Europe (EUR and GBP), 2019u20132030
                    • Therapeutic BTX Market Growth, by Country, Europe, 2020u20132030
                    • Therapeutic BTX Market, by Indication, France (USD and EUR), 2019u20132030
                    • Therapeutic BTX Market, by Indication, Germany (USD and EUR), 2019u20132030
                    • Therapeutic BTX Market, by Indication, Italy (USD and EUR), 2019u20132030
                    • Therapeutic BTX Market, by Indication, Spain (USD and EUR), 2019u20132030
                    • Therapeutic BTX Market, by Indication, UK (USD and EUR), 2019u20132030
                    • Therapeutic BTX Market, by Indication, UK (GBP), 2019u20132030
                  • Competitive Highlights
                    • Market Shares
                      • Therapeutic BTX Revenue Market Shares, Europe, 2020
                      • Therapeutic BTX Revenue Market Shares, by Country, Europe, 2020
                    • Competitive Factors and Strategies
                      • Competitive Factors and Strategies, by Country, Europe
                  • Asia Pacific Therapeutic Botulinum Toxin Market
                    • Market Highlights
                      • Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019u20132030
                    • Market Definitions
                      • Market Forecast Data
                        • Therapeutic BTX Procedures, by Indication, Asia Pacific, 2019u20132030
                        • Therapeutic BTX Procedures, by Country, Asia Pacific, 2019u20132030
                        • Therapeutic BTX Procedures, by Indication, Australia, 2019u20132030
                        • Spasticity Therapeutic BTX Procedures, by Anatomy, Australia, 2019u20132030
                        • Spasticity Therapeutic BTX Procedures, by Age Group, Australia, 2019u20132030
                        • Overactive Bladder Therapeutic BTX Procedures, by Cause, Australia, 2019u20132030
                        • Therapeutic BTX Procedures, by Indication, Japan, 2019u20132030
                        • Therapeutic BTX Market, by Indication, Asia Pacific (USD), 2019u20132030
                        • Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019u20132030
                        • Therapeutic BTX Market, by Indication, Australia (USD), 2019u20132030
                        • Therapeutic BTX Market, Australia (USD), 2019u20132030
                        • Therapeutic BTX Market, by Indication, Japan (USD), 2019u20132030
                        • Therapeutic BTX Market, Japan (USD), 2019u20132030
                      • Competitive Highlights
                        • Market Shares
                          • Therapeutic BTX Revenue Market Shares, Asia Pacific, 2020
                          • Therapeutic BTX Revenue Market Shares, by Country, Asia Pacific, 2020
                        • Competitive Factors and Strategies
                          • Competitive Factors and Strategies, by Country, Asia Pacific
                      • Appendix
                        • Abbreviations
                          • Bibliography